We are live on ! Find out more
IMED

PureFunds ETFx HealthTech ETF

Delisted

IMED was delisted on the 6th of September, 2017.

2 hedge funds and large institutions have $915K invested in PureFunds ETFx HealthTech ETF in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 12 (+1)

64% less capital invested

Capital invested by funds: $2.56M → $915K (-$1.65M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$818

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$1.46M
Name Holding Trade Value Shares
Change
Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$914K -$1.46M -60,890 -61%
UBS Group
2
UBS Group
Switzerland
$1K +$818 +34 New

IMED Hedge Fund Activity: Q4 2016 in Review

2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PureFunds ETFx HealthTech ETF (IMED) for Q4 2016, worth a combined $915K — down 64% from $2.56M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new IMED positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $818. The largest seller was Virtu KCG Holdings, cutting an estimated $1.46M.

  • 2 institutional investors held PureFunds ETFx HealthTech ETF (IMED) as of Q4 2016, up from 1 in Q3 2016.
  • Funds reported $915K of PureFunds ETFx HealthTech ETF stock for Q4 2016, down 64% quarter-over-quarter.
  • 1 fund opened new PureFunds ETFx HealthTech ETF positions in Q4 2016 and 0 closed out, a net change of +1 holder.
  • The largest PureFunds ETFx HealthTech ETF buyer in Q4 2016 was UBS Group, an estimated $818 added.
  • The largest PureFunds ETFx HealthTech ETF seller in Q4 2016 was Virtu KCG Holdings, an estimated $1.46M sold.

Based on aggregated 13F filings for Q4 2016.